Drugs / Tegafur-Ugotex
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07161453 Comparator | Sep 2025 → Sep 2027 expected | gastroesophageal junction adenocarcinoma | Liaoning Cancer Hospital & Institute | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tegafur-Ugotex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07161453 ↗ |